The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly

European Journal of Clinical Investigation

Volumn 38, Issue 7, 2008, Pages 469-475

  Wen, C J ^a   Lee, Y S ^a   Lin, W Y ^b   Huang, H L ^a   Yao, C A ^a   Sung, P K ^c   Huang, K C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c MJ Health Screening Center   (Taiwan)

Author keywords

All cause; Cardiovascular disease; Elderly; Metabolic syndrome; Mortality; Taiwanese

Indexed keywords

CHOLESTEROL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL RESEARCH; METABOLIC SYNDROME X; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SMOKING; TAIWAN;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; TAIWAN; TIME FACTORS;

EID: 45149114556     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.01965.x     Document Type: Article

References (32)

1. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004 33 : 351 75.
2. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 2004 33 : 333 50.
3. Lakka HM. Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 288 : 2709 16.
4. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003 26 : 3153 9.
5. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005 112 : 666 73.
6. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005 28 : 385 90.
7. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 : 3066 72.
8. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006 37 : 806 11.
9. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005 28 : 1769 78.
10. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004 110 : 1245 50.
11. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004 164 : 1066 76.
12. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004 110 : 1251 7.
13. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365 : 1415 28.
14. Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 2007 117 : 204 10.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 2002 287 : 356 9.
16. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006 105 : 626 35.
17. Huang KC, Lee MS, Lee SD, Chang YH, Lin YC, Tu SH et al. Obesity in the elderly and its relationship with cardiovascular risk factors in Taiwan. Obes Res 2005 13 : 170 8.
18. Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006 29 : 2471 6.
19. Shen YH, Yang WS, Lee TH, Lee LT, Chen CY, Huang KC. Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults. Obes Res 2005 13 : 1238 45.
20. Huang KC, Lin WY, Lee LT, Chen CY, Lo H, Hsia HH et al. Four anthropometric indices and cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002 26 : 1060 8.
21. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006 17 : 2937 44.
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 52.
23. Lee ET, Go OT. Survival analysis in public health research. Annu Rev Public Health 1997 18 : 105 34.
24. Ghali WA, Quan H, Brant R, van Melle G, Norris CM, Faris PD et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA 2001 286 : 1494 7.
25. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals. prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005 28 : 882 7.
26. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007 28 : 857 64.
27. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003 108 : 414 9.
28. Simons LA, Simons J, Friedlander Y, McCallum J. Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study. Med J Aust 2007 186 : 400 3.
29. Hong Y, Jin X, Mo J, Lin HM, Duan Y, Pu M et al. Metabolic syndrome, its pre-eminent clusters, incident coronary heart disease and all-cause mortality - results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med 2007 262 : 113 22.
30. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007 30 : 2381 7.
31. Lee J, Ma S, Heng D, Tan CE, Chew SK, Hughes K et al. Should central obesity be an optional or essential component of the metabolic syndrome? Ischaemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care 2007 30 : 343 7.
32. Khoo CM, Liew CF, Chew SK, Tai ES. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome. Obesity 2007 15 : 262 9.